Functional and structural efficacy of a novel combinational therapy of aflibercept and timely focal/grid photocoagulation in diabetic macular oedema: do clinical study results compare favourably with a standard-of-care treated real-world population?
Mathias M JørgensenAnders Højslet VestergaardSøren Leer BlindbækTunde PetoJakob GrauslundPublished in: Acta ophthalmologica (2022)
In comparison to a matched, real-world DME-population, patients in combined treatment with intravitreal aflibercept and postloading focal/grid photocoagulation obtained a better functional outcome despite having received fewer intravitreal injections. Future randomized studies are needed to evaluate the long-term efficacy of this combined treatment regimen.
Keyphrases
- diabetic retinopathy
- age related macular degeneration
- end stage renal disease
- newly diagnosed
- type diabetes
- vascular endothelial growth factor
- healthcare
- double blind
- chronic kidney disease
- ejection fraction
- optical coherence tomography
- palliative care
- prognostic factors
- peritoneal dialysis
- clinical trial
- stem cells
- combination therapy
- patient reported outcomes
- cell therapy
- health insurance
- patient reported